Newland Pharmaceutical Co., Ltd. (SHE:301277)
China flag China · Delayed Price · Currency is CNY
11.53
0.00 (0.00%)
Apr 29, 2026, 4:00 PM EDT

Newland Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2019
Cash & Equivalents
123.89169281.58270.0251.1334.21
Upgrade
Trading Asset Securities
542.35549.55525.16589.5701.368.67
Upgrade
Cash & Short-Term Investments
666.23718.55806.75859.52752.4942.88
Upgrade
Cash Growth
-15.40%-10.93%-6.14%14.22%1654.94%17.63%
Upgrade
Accounts Receivable
368.82270.55332.61240.9360.46269.6
Upgrade
Other Receivables
0.190.030.060.190.260.16
Upgrade
Receivables
369.01270.58332.67241.09360.72269.76
Upgrade
Inventory
66.3572.3745.063153.5278.57
Upgrade
Other Current Assets
4.215.1810.5525.0420.389.8
Upgrade
Total Current Assets
1,1061,0671,1951,1571,187401
Upgrade
Property, Plant & Equipment
648.08659.65574.78388.2295.52225.67
Upgrade
Other Intangible Assets
49.5249.9936.8238.0838.7739.71
Upgrade
Long-Term Deferred Tax Assets
-----1.01
Upgrade
Long-Term Deferred Charges
0.921.343.385.611.29-
Upgrade
Other Long-Term Assets
18.291.853.7320.9611.080.51
Upgrade
Total Assets
1,8231,7801,8141,6101,534667.9
Upgrade
Accounts Payable
105.5197.68138.6687.75106.3780.26
Upgrade
Accrued Expenses
14.8924.3723.7830.3318.1827.81
Upgrade
Short-Term Debt
0.47-0.73--91.33
Upgrade
Current Portion of Long-Term Debt
-----4.66
Upgrade
Current Portion of Leases
-2.81-1.992.84-
Upgrade
Current Income Taxes Payable
8.290.06---3.05
Upgrade
Current Unearned Revenue
4.473.285.324.434.611.68
Upgrade
Other Current Liabilities
40.4842.1748.314.9624.0111.8
Upgrade
Total Current Liabilities
174.11170.35216.78139.47156.01220.58
Upgrade
Long-Term Debt
-----30.39
Upgrade
Long-Term Leases
1.392.892.250.732.88-
Upgrade
Long-Term Unearned Revenue
50.1344.2341.8810.0410.310.56
Upgrade
Long-Term Deferred Tax Liabilities
10.511.029.779.785.39-
Upgrade
Total Liabilities
236.14228.49270.69160.02174.58261.53
Upgrade
Common Stock
392.08392.08280.06200.04133.36100
Upgrade
Additional Paid-In Capital
532.74532.74644.77724.78791.465.49
Upgrade
Retained Earnings
656.03619.93610.7517.09424.79292.48
Upgrade
Comprehensive Income & Other
6.286.596.676.116.334.56
Upgrade
Total Common Equity
1,5871,5511,5421,4481,356402.53
Upgrade
Minority Interest
-0.65-0.330.851.473.253.85
Upgrade
Shareholders' Equity
1,5861,5511,5431,4491,359406.38
Upgrade
Total Liabilities & Equity
1,8231,7801,8141,6101,534667.9
Upgrade
Total Debt
1.865.692.982.725.72126.38
Upgrade
Net Cash (Debt)
664.37712.86803.77856.8746.77-83.5
Upgrade
Net Cash Growth
-15.10%-11.31%-6.19%14.73%--
Upgrade
Net Cash Per Share
1.701.822.042.192.48-0.28
Upgrade
Filing Date Shares Outstanding
391.97392.08392.08392.08392.08294
Upgrade
Total Common Shares Outstanding
391.97392.08392.08392.08392.08294
Upgrade
Working Capital
931.71896.33978.241,0171,031180.43
Upgrade
Book Value Per Share
4.053.963.933.693.461.37
Upgrade
Tangible Book Value
1,5381,5011,5051,4101,317362.82
Upgrade
Tangible Book Value Per Share
3.923.833.843.603.361.23
Upgrade
Buildings
-380.5211.94169.21151.69148.36
Upgrade
Machinery
-467.7295.69235.66187.31125.82
Upgrade
Construction In Progress
-13.46222.1106.755.3533.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.